Stay updated on Nivolumab in Resectable Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable Osteosarcoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:20:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No other visible changes to study details.
    Difference
    0.0%
    Check dated 2026-03-11T17:41:33.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Administrative updates were made: a new revision (v3.4.2) and several date stamps were added. Older notices and some institutional references were removed, with no changes to the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T05:33:41.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T05:12:08.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Show glossary option added and footer/metadata expanded with additional links and terminology (MeSH terms and related terms). Removed the No FEAR Act data note.
    Difference
    62%
    Check dated 2026-01-28T03:20:55.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; the screenshots indicate only a metadata/version change with no substantive changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:52:04.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable Osteosarcoma Clinical Trial page.